Utility of Biomarkers in Obstetric Patients With Preeclampsia
- 13/03/2023
Preeclampsia is a complex syndrome whose complications bear an impact on perinatal morbidity and mortality. Angiogenic biomarkers may significantly impact both the decision to admit patients and risk stratification and may also help guide patient management and level of care. Preeclampsia is one of the main causes of maternal and foetal morbimortality, with a global incidence of 3-5%, and...
READ MORE